PRGO — PERRIGO Co plc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1585364 ·
Last close
$10.80
Market Cap
$1.49B
52W High
$13.98
52W Low
$9.23
ADV30
2,300,156
Next earnings
2026-07-31
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 1,109,600,000 | 362,200,000 | 84,400,000 | -1,418,100,000 | 8,535,200,000 | 531,600,000 | 5,599,700,000 |
| Sep 2025 | 1,043,300,000 | 377,100,000 | 93,400,000 | 7,500,000 | 10,084,000,000 | 432,100,000 | 5,637,500,000 |
| Jun 2025 | 1,056,300,000 | 362,900,000 | 55,600,000 | -8,400,000 | 10,094,100,000 | 454,200,000 | 5,621,800,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$238,500,000
Investing CF
$-75,400,000
Financing CF
$-220,500,000
CapEx
$-93,400,000
Dividends Paid
$-159,300,000
Buybacks
—
EPS Diluted TTM
$-13.10
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,677,500,000
Inventory
$1,149,000,000
Receivables
$612,800,000
ST Investments
—
EBIT TTM
$-1,135,300,000
Pretax Income TTM
$-1,297,800,000
Interest Exp TTM
$162,500,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,178,400,000
EBITDA
$637,299,968
Free Cash Flow
$108,425,000
Enterprise Value
$5,023,986,176
Total Cash
$357,200,000
Total Debt
$3,828,699,904
Shares Out
138,367,770
Trailing EPS
$-12.93
Book Value
$21.33
ROE
-52.2%
ROA
2.1%
Div Yield
10.34%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,253,100,000 | 312,800,000 | -1,425,400,000 | 8,535,200,000 | 5,599,700,000 | — | 238,500,000 |
| Dec 2024 | 4,373,400,000 | 311,900,000 | -171,800,000 | 9,647,700,000 | 5,328,300,000 | — | 362,900,000 |
| Dec 2023 | 4,655,600,000 | 284,100,000 | -12,700,000 | 10,809,100,000 | 6,041,200,000 | — | 405,500,000 |
| Dec 2022 | 4,451,600,000 | 121,400,000 | -140,600,000 | 11,017,300,000 | 6,175,200,000 | — | 307,300,000 |
TTM Snapshot
Revenues TTM
$4,354,200,000
NetIncome TTM
$-115,100,000
OpCashFlow TTM
$0
Assets (Latest)
$9,647,700,000
Forward EPS
$2.36
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | $1.51B | $8.12 | — |
| MBX | MBX Biosciences, Inc. | $1.51B | $31.75 | — |
| PGEN | PRECIGEN, INC. | $1.51B | $4.24 | — |
| BHVN | Biohaven Ltd. | $1.52B | $10.07 | — |
| AMLX | Amylyx Pharmaceuticals, Inc. | $1.52B | $13.68 | — |
News headlines (Yahoo Finance, 1h cache)
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
2026-05-26 12:30 · Yahoo
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
2026-05-07 16:56 · Yahoo
Assessing Perrigo (PRGO) Valuation After Weak Q1 Results And Lowered Guidance
2026-05-07 14:21 · Yahoo
Perrigo Company plc Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo
Perrigo (PRGO) Q1 Earnings Beat Estimates
2026-05-06 11:45 · Yahoo
Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations
2026-05-06 10:30 · Yahoo
How Investors Are Reacting To Perrigo (PRGO) Dermacosmetics Sale, Dividend Payout, And Infant Formula Strains
2026-05-05 23:24 · Yahoo
Perrigo Completes Divestiture of Dermacosmetics Business
2026-04-30 20:30 · Yahoo
ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth
2026-04-30 14:00 · Yahoo
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
2026-04-29 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.